The Sexual Health Conversation Nobody Wants to Have — But Everyone Needs To
Sexual health is one of the most important and most underreported dimensions of quality of life in middle-aged and older adults. Survey research consistently shows that sexual dysfunction — reduced desire, performance difficulties, pain during intercourse, relationship strain from sexual disengagement — is among the top quality-of-life concerns for adults in their 40s, 50s, and beyond. It is also one of the most direct, measurable consequences of hormonal decline.
Hormone therapy addresses the biological foundation of sexual function in ways that counseling, lifestyle changes, and over-the-counter supplements cannot replicate — because the root cause is physiological, not psychological.
Sexual Health in Men: What Low Testosterone Does
Testosterone is the primary driver of male sexual desire and function. Its role in sexual health encompasses: initiating desire (libido) through dopamine and androgen receptor-mediated pathways in the brain’s reward and sexual motivation circuits; supporting erectile function through nitric oxide signaling in penile vascular tissue; maintaining genital sensitivity; and driving the motivation and energy that support intimate relationships.
Low testosterone in men produces a characteristic sexual dysfunction pattern: libido declines first (often described as reduced interest, reduced frequency of initiation, reduced responsiveness to stimulation), followed by reduced morning erections, difficulty with arousal, and often secondary erectile dysfunction from reduced vascular and neurological stimulation.
TRT — particularly when serum levels are restored to the 700–1,000 ng/dL range — typically produces significant improvement in all of these domains. In the first 3–6 weeks, libido and morning erections commonly return. By 2–3 months, erectile function, arousal response, and sexual confidence are substantially improved in most men with confirmed hypogonadism.
Sexual Health in Women: The Multi-Hormone Picture
Female sexual dysfunction in midlife involves multiple hormonal drivers simultaneously:
Testosterone deficiency is the primary cause of low libido in women, regardless of menopausal status. Women with documented low free testosterone consistently report reduced sexual desire, diminished arousal, and reduced orgasm intensity. Low-dose testosterone therapy — the most underused tool in women’s hormone medicine — produces striking improvement in sexual desire and arousal in many women where estrogen and progesterone alone have not.
Estrogen deficiency causes vaginal atrophy (genitourinary syndrome of menopause — GSM): thinning of vaginal and urethral tissue, loss of lubrication, increased fragility, and often dyspareunia (pain during intercourse). Local vaginal estrogen (cream, suppository, or ring) is highly effective for GSM with minimal systemic absorption — appropriate even for women who choose not to use systemic HRT. Without addressing GSM, sex is painful regardless of desire or arousal — a physical barrier that no amount of willingness can overcome.
Progesterone’s GABAergic effects reduce anxiety and support emotional availability for intimacy — important for women whose sexual reluctance is driven partly by stress, mental load, and emotional depletion rather than purely libido-related factors.
Relationship Benefits Beyond the Bedroom
Sexual health is a dimension of overall relationship health. Couples who experience hormonal sexual dysfunction frequently report relationship tension, reduced non-sexual intimacy, emotional distance, and communication difficulties that extend beyond the bedroom. Restoring sexual health through hormone therapy frequently produces improvements in relationship quality that patients describe as transformative — not merely physical but deeply relational.
Sexual dysfunction is not inevitable with age, and it is not something you have to accept. Call Multigen Wellness at (800) 259-0015 to discuss hormone evaluation for sexual health today.